New Mexico Cannabis Rescheduling Update

New Mexico Cannabis Rescheduling Update: What It Means for Patients, Consumers, and Businesses

The New Mexico Cannabis Control Division (CCD) has released a new industry bulletin providing an update on recent federal cannabis rescheduling developments. While federal regulators continue to evaluate changes to cannabis scheduling under the Controlled Substances Act, New Mexico officials are emphasizing that current state cannabis laws remain fully in effect.

According to the June 16, 2026 bulletin, the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) issued a federal order on April 22, 2026 concerning the rescheduling of certain cannabis products. The announcement also initiated additional federal administrative proceedings, including a hearing currently scheduled for June 29, 2026.

Since the federal order was issued, multiple legal challenges have been filed in federal court. Several petitions seeking judicial review have been consolidated before the United States Court of Appeals for the District of Columbia Circuit. Additional motions seeking to delay or block implementation of portions of the federal order are still pending.

For New Mexico cannabis businesses, however, the message from regulators is straightforward: continue operating exactly as required under existing state law. The CCD specifically stated that all licensees must continue complying with the Cannabis Regulation Act, the Lynn and Erin Compassionate Use Act, and all rules administered by the division.

The agency also noted that federal rescheduling does not automatically change New Mexico's licensing requirements, testing standards, packaging and labeling rules, transportation restrictions, enforcement authority, or other state regulatory obligations. Until further guidance is issued, all current state requirements remain enforceable.

The bulletin additionally addressed interstate cannabis commerce. While New Mexico law contains provisions that may allow interstate or international cannabis commerce under certain circumstances, the state has not issued any determinations regarding the activation or implementation of those provisions.

For consumers, patients, and industry participants, the takeaway is that no immediate operational changes have occurred in New Mexico. Dispensaries remain subject to the same regulations, products remain subject to the same testing requirements, and cannabis sales continue under the state's existing framework.

Dispensary Near Me will continue monitoring federal and state developments and will provide updates as new information becomes available. As the legal and regulatory landscape continues to evolve, staying informed remains essential for both businesses and consumers throughout New Mexico's cannabis industry.